Depression and Anxiety Trial, Recruiting NCT06632782 Sponsor: Dasman Diabetes Institute Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06632782
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes for more than 1 year
  • People whose blood sugar control (measured by a test called HbA1c) falls between 5.7% and 9.5%
  • People with type 2 diabetes who are over 30 years old and are currently taking diabetes tablets or insulin
  • People who have no known heart problems
  • People who score 8.0 or above on standard questionnaires measuring anxiety and depression
  • People who are able to focus on their breathing and are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have type 1 diabetes
  • People who are currently taking antidepressant medication
  • People who have been diagnosed with bipolar disorder
  • People who have had a serious heart event (such as a heart attack) in the past 6 months
  • People who have an active kidney disease, or who are on dialysis or have had a kidney transplant
  • People who have an artificial pacemaker
  • People who have taken part in a breath awareness or yoga course within the past 6 months
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rashmi Shiju, Dasman Diabetes Institute

Phone: 22242999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dasman Diabetes Institute
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 November 2026

Where this trial is recruiting

Kuwait

Primary endpoints

Change in Hospital Anxiety and depression score(HADS); Change in Patient Health Questionnaire PHQ-9 score; Change in Pitssburgh Sleep Quality Index PSQI score; Change inMindful Attention Awareness Scale (MAAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov